Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -454.60K | -1.17M | -1.56M | -1.60M | -1.97M |
| Total Depreciation and Amortization | 46.70K | -1.80K | 22.40K | 23.80K | 25.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.60K | 436.50K | 449.90K | 127.40K | 144.80K |
| Change in Net Operating Assets | 364.50K | 415.30K | 276.30K | 229.90K | -24.60K |
| Cash from Operations | -84.00K | -324.30K | -806.40K | -1.22M | -1.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.00K | 32.00K | 32.00K | 32.00K | -- |
| Cash from Investing | 32.00K | 32.00K | 32.00K | 32.00K | -- |
| Total Debt Issued | 101.60K | 473.50K | 1.02M | 1.66M | 2.56M |
| Total Debt Repaid | -42.20K | -84.10K | -168.80K | -167.90K | -165.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 43.60K | 285.60K | 626.00K | 1.10M | 1.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 110.70K | -1.60K | -1.60K |
| Net Change in Cash | -8.40K | -6.70K | -37.70K | -89.10K | -64.00K |